Clinical Study
Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
Table 2
Cox regression model—PSA relapse.
| | Univariate analysis | Multivariate analysis | | HR | (95% CI) | | HR | (95% CI) | |
| Age at diagnosis, continuous | 0.99 | (0.93–1.06) | 0.741 | 0.99 | (0.93–1.05) | 0.726 | T-stage | | | | | | | T1 | 1.00 | (ref.) | — | 1.00 | (ref.) | — | T2 | 4.25 | (0.90–20.02) | 0.067 | 3.63 | (0.76–17.36) | 0.106 | T3 | 16.70 | (3.92–71.11) | <0.001 | 9.67 | (2.13–43.89) | 0.003 | T4 | 45.91 | (6.41–329.02) | <0.001 | 14.80 | (1.82–120.24) | 0.012 | Gleason score, continuous | 2.05 | (1.53–2.75) | <0.001 | 1.43 | (1.02–2.00) | 0.038 | log-PSA, continuous | 2.27 | (1.54–3.34) | <0.001 | 1.40 | (0.92–2.14) | 0.115 | Rectal rod | | | | | | | No | 1.00 | (ref.) | — | 1.00 | (ref.) | — | Yes | 1.99 | (0.93–4.25) | 0.074 | 1.21 | (0.53–2.76) | 0.653 |
|
|